{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:59:25Z","timestamp":1792083565628,"version":"4.4.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.cca.2026.121249","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T17:25:09Z","timestamp":1785086709000},"page":"121249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Diagnostic pitfall: NSAID-induced membranous nephropathy with PLA2R positivity, IgG1-predominant deposits, C1q positivity, and concurrent acute interstitial nephritis\u2014A case report"],"prefix":"10.1016","volume":"593","author":[{"given":"Jingzhen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cca.2026.121249_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.cca.2026.121249_bb0010","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2215\/CJN.11761116","article-title":"Primary membranous nephropathy","volume":"12","author":"Couser","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.cca.2026.121249_bb0015","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.kint.2023.06.032","article-title":"Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification","volume":"104","author":"Sethi","year":"2023","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.cca.2026.121249_bb0020","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO 2021 guideline for the Management of Glomerular Diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.cca.2026.121249_bb0025","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1681\/ASN.0000000719","article-title":"Drug-induced membranous nephropathy: piecing together clues to understand disease mechanisms","volume":"36","author":"Avasare","year":"2025","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.cca.2026.121249_bb0030","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.kint.2023.04.006","article-title":"Proprotein convertase subtilisin\/kexin type 6 (PCSK6) is a likely antigenic target in membranous nephropathy and nonsteroidal anti-inflammatory drug use","volume":"104","author":"Sethi","year":"2023","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2026.121249_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1009864","article-title":"The role of the complement system in primary membranous nephropathy: a narrative review in the era of new therapeutic targets","volume":"13","author":"So","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121249_bb0040","doi-asserted-by":"crossref","first-page":"1323432","DOI":"10.3389\/fneph.2024.1323432","article-title":"NELL1 membranous nephropathy: clinical associations provide mechanistic clues","volume":"4","author":"Andeen","year":"2024","journal-title":"Front. Nephrol."},{"issue":"9","key":"10.1016\/j.cca.2026.121249_bb0045","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/j.ekir.2023.06.001","article-title":"Membranous nephropathy after exposure to immune checkpoint inhibitors","volume":"8","author":"Benyahia","year":"2023","journal-title":"Kidney Int. Reports"},{"key":"10.1016\/j.cca.2026.121249_bb0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fmed.2018.00101","article-title":"Diagnostic test accuracy of serum anti-PLA2R autoantibodies and glomerular PLA2R antigen for diagnosing idiopathic membranous nephropathy: an updated Meta-analysis","volume":"5","author":"Li","year":"2018","journal-title":"Front. Med."},{"issue":"5","key":"10.1016\/j.cca.2026.121249_bb0055","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.ajkd.2013.03.045","article-title":"Membranous nephropathy and nonsteroidal anti-inflammatory agents","volume":"62","author":"Nawaz","year":"2013","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"10.1016\/j.cca.2026.121249_bb0060","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.kint.2023.10.035","article-title":"Complement activation and effector pathways in membranous nephropathy","volume":"105","author":"Kistler","year":"2024","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.cca.2026.121249_bb0065","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.ekir.2025.03.050","article-title":"Update on acute tubulointerstitial nephritis: clinical features, immunologic insights, and diagnostic and treatment approaches","volume":"10","author":"Sahutoglu","year":"2025","journal-title":"Kidney Int. Reports"},{"issue":"8","key":"10.1016\/j.cca.2026.121249_bb0070","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2215\/CJN.11290821","article-title":"Drug-induced acute kidney injury","volume":"17","author":"Perazella","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.cca.2026.121249_bb0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/BOR.0000000000001059","article-title":"Polymyalgia rheumatica and giant cell arteritis: diagnosis and management","volume":"37","author":"Sun","year":"2025","journal-title":"Curr. Opin. Rheumatol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126004316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126004316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:28:03Z","timestamp":1792081683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126004316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":15,"alternative-id":["S0009898126004316"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121249","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic pitfall: NSAID-induced membranous nephropathy with PLA2R positivity, IgG1-predominant deposits, C1q positivity, and concurrent acute interstitial nephritis\u2014A case report","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121249","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121249"}}